Personalized cancer vaccine shows promise, experts weigh in

Moderna and Merck have developed a personalized mRNA vaccine for melanoma that uses AI to target unique cancer cells in individual patients. When combined with existing drugs, the treatment reduces the risk of cancer returning or spreading. This breakthrough represents a shift toward personalized oncology, with potential future applications for other aggressive cancers.